Skip to main content

Table 2 Univariate analysis of the association between prognostic variables and overall survival in NSCLC

From: Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients

Variables

Hazard ratio (95% CI)

p value

Age

1.01 (0.99–1.04)

0.267

Tumor grade

1.22 (0.93–1.60)

0.146

pT stage

3.57 (2.21–5.76)

 < 0.001

pN stage

2.59 (1.72–3.91)

 < 0.001

CD68high

0.62 (0.41–0.94)

0.024

CD163high

0.89 (0.60–1.35)

0.594

VEGF-Ahigh

0.68 (0.45–1.03)

0.071

VEGF-Chigh

1.14 (0.76–1.71)

0.531

M2 ratiohigh

1.61 (1.07–2.44)

0.024

Dual M2 ratiohigh & VEGF-Ahigh

1.23 (0.74–2.02)

0.424

Dual M2 ratiohigh & VEGF-Chigh

1.82 (1.18–2.80)

0.007

  1. M2 ratio, CD163+/CD68+
  2. NSCLC non-small cell lung cancer, CI confidence interval, VEGF vascular endothelial growth factor